MX2014004794A - Seleccion de protocolo preferido de manejo y procesamiento de muestras para identificacion de biomarcadores de enfermedad y valoracion de calidad de muestra. - Google Patents

Seleccion de protocolo preferido de manejo y procesamiento de muestras para identificacion de biomarcadores de enfermedad y valoracion de calidad de muestra.

Info

Publication number
MX2014004794A
MX2014004794A MX2014004794A MX2014004794A MX2014004794A MX 2014004794 A MX2014004794 A MX 2014004794A MX 2014004794 A MX2014004794 A MX 2014004794A MX 2014004794 A MX2014004794 A MX 2014004794A MX 2014004794 A MX2014004794 A MX 2014004794A
Authority
MX
Mexico
Prior art keywords
identification
selection
disease biomarkers
quality assessment
sample
Prior art date
Application number
MX2014004794A
Other languages
English (en)
Inventor
Stephen Alaric Williams
Michael Riel-Mehan
Edward N Brody
Alex A E Stewart
Glenn Sanders
Rachel M Ostroff
Original Assignee
Somalogic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somalogic Inc filed Critical Somalogic Inc
Publication of MX2014004794A publication Critical patent/MX2014004794A/es

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Public Health (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La presente invención se refiere a métodos para obtener muestras biológicas de calidad mejorada. Abarca la identificación de marcadores o proteínas o muestras biológicas que se alteran debido a variaciones que se alteran debido a variaciones en la recolección, manejo y procesamiento de muestras. También son útiles para corregir variaciones en los resultado medidos para biomarcadores de enfermedad. Adicionalmente, pueden permitir el rechazo de muestras o de grupos de muestras conforme sea necesario si se determina que es un método de recolección no estuvo de acuerdo con el protocolo predeterminado. En la presente se describen otras ventajas útiles para la persona experta en la técnica.
MX2014004794A 2011-10-24 2012-10-24 Seleccion de protocolo preferido de manejo y procesamiento de muestras para identificacion de biomarcadores de enfermedad y valoracion de calidad de muestra. MX2014004794A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161550688P 2011-10-24 2011-10-24
PCT/US2012/061722 WO2013063139A1 (en) 2011-10-24 2012-10-24 Selection of preferred sample handling and processing protocol for identification of disease biomarkers and sample quality assessment

Publications (1)

Publication Number Publication Date
MX2014004794A true MX2014004794A (es) 2014-05-30

Family

ID=48136649

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014004794A MX2014004794A (es) 2011-10-24 2012-10-24 Seleccion de protocolo preferido de manejo y procesamiento de muestras para identificacion de biomarcadores de enfermedad y valoracion de calidad de muestra.

Country Status (10)

Country Link
US (1) US20130103321A1 (es)
EP (1) EP2771451A1 (es)
JP (1) JP2014531046A (es)
KR (1) KR20150044834A (es)
CN (1) CN103958662A (es)
AU (1) AU2012328864A1 (es)
CA (1) CA2850525A1 (es)
IL (1) IL231719A0 (es)
MX (1) MX2014004794A (es)
WO (1) WO2013063139A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2954863A1 (en) * 2014-07-28 2016-02-04 Metanomics Health Gmbh Means and methods for assessing a quality of a biological sample
US10890592B2 (en) 2015-11-04 2021-01-12 Metabolon, Inc. Automated sample quality assessment
WO2018170443A1 (en) * 2017-03-16 2018-09-20 Counsyl, Inc. Multi-dimensional sample-dependent and batch-dependent quality control
WO2018203885A1 (en) * 2017-05-02 2018-11-08 Liquid Biosciences, Inc. Systems and methods for determining attributes of biological samples
WO2019013256A1 (ja) * 2017-07-11 2019-01-17 国立研究開発法人医薬基盤・健康・栄養研究所 生物学的検体の品質評価方法およびそのためのマーカー
SG11202103884UA (en) * 2018-10-30 2021-05-28 Somalogic Inc Methods for sample quality assessment
CN109725900B (zh) * 2019-01-07 2021-01-05 西北工业大学 寄存器传输级Verilog代码的SMV模型构建方法
JP7192976B2 (ja) * 2019-05-09 2022-12-20 株式会社島津製作所 試料の評価方法、分析方法、劣化試料の検出方法、劣化血漿試料検出用マーカーおよび劣化血清試料検出用マーカー
US20240256225A1 (en) * 2020-08-06 2024-08-01 Prenosis, Inc. Systems and methods for normalization of machine learning datasets
CN113049664B (zh) * 2021-03-15 2022-11-22 东华理工大学 一种基于质谱代谢组学的通路分析建模方法
KR20240137560A (ko) * 2022-01-21 2024-09-20 소마로직 오퍼레이팅 컴퍼니, 인코포레이티드 샘플 품질 평가 방법
WO2023211770A1 (en) * 2022-04-24 2023-11-02 Somalogic Operating Co., Inc. Methods for sample quality assessment
AU2023260315A1 (en) * 2022-04-24 2024-09-12 Somalogic Operating Co., Inc. Methods for sample quality assessment
CN118829884A (zh) * 2022-04-24 2024-10-22 私募蛋白质体操作有限公司 用于样品质量评估的方法
CN118805086A (zh) * 2022-04-24 2024-10-18 私募蛋白质体操作有限公司 用于样品质量评估的方法
WO2024015486A1 (en) * 2022-07-14 2024-01-18 Somalogic Operating Co., Inc. Methods for sample quality assessment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060024690A1 (en) * 2003-09-19 2006-02-02 Kao H P Normalization of data using controls
CA2601623C (en) * 2005-03-14 2018-10-23 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for evaluating graft survival in a solid organ transplant recipient
US8735085B2 (en) * 2007-10-05 2014-05-27 Becton, Dickinson And Company Method for diagnosing diseases using a protein or degradation product based on half-life
EP2960342A1 (en) * 2009-04-14 2015-12-30 Nestec S.A. Inflammatory bowel disease prognostics

Also Published As

Publication number Publication date
EP2771451A1 (en) 2014-09-03
US20130103321A1 (en) 2013-04-25
CN103958662A (zh) 2014-07-30
AU2012328864A1 (en) 2014-04-17
WO2013063139A1 (en) 2013-05-02
CA2850525A1 (en) 2013-05-02
IL231719A0 (en) 2014-05-28
JP2014531046A (ja) 2014-11-20
KR20150044834A (ko) 2015-04-27

Similar Documents

Publication Publication Date Title
MX2014004794A (es) Seleccion de protocolo preferido de manejo y procesamiento de muestras para identificacion de biomarcadores de enfermedad y valoracion de calidad de muestra.
WO2014151764A3 (en) Methods and compositions for classification of samples
MX2019005199A (es) Métodos para evaluar el riesgo usando and libre de células total y específico.
MX2016016902A (es) Metodos para analizar acidos nucleicos de celulas individuales o poblaciones de celulas.
MX2021006791A (es) Metodos y composiciones para detectar proteinas mal plegadas.
EP3967769A3 (en) Lung cancer detection kit or device, and detection method
MX346624B (es) Sistema y metodo para la deteccion de anormalidades en una muestra biologica.
EP3654036A3 (en) Stomach cancer biomarker and detection method
EP4292654A3 (en) Detection of misfolded proteins
WO2013190075A3 (en) Specific biomarkers for hepatocellular carcinoma (hcc)
EA201590027A1 (ru) Способы детекции заболеваний или состояний
WO2015131151A3 (en) Method and apparatus for determining markers of health by analysis of blood
WO2015131169A3 (en) Personalized myeloma detection
WO2016127077A8 (en) Systems and methods for detection and analysis of biological species
EP2738554A4 (en) BIOINFORMATICS PLATFORM FOR HIGH-PURITY IDENTIFICATION AND QUANTIFICATION OF N-GLYCOPEPTIDE
WO2013166444A3 (en) Biomarker analysis using scodaphoresis
WO2013144986A3 (en) Composition for processing histological, postmortem, cytological samples
EP3208333A4 (en) Method for detecting and quantifying target nucleic acid in test sample using novel positive control nucleic acid
WO2015077382A3 (en) Combined cytology and molecular testing for early detection of esophageal adenocarcinoma
WO2011037827A3 (en) Identification of discriminant proteins through antibody profiling, methods and apparatus for identifying an individual
MX2017009752A (es) Adn huesped como biomarcador de la enfermedad de crohn.
EA201691168A1 (ru) Способы исследования бета-глюкана
WO2014181215A3 (en) Method for determining free copper
MX341181B (es) Metodo para someter a prueba a un sujeto que se cree esta predispuesto a tener cancer metastasico usando delta133p53beta.
EP3919906A4 (en) METHODS FOR IMMUNOLOGICAL ANALYSIS OF FREE TARGETS IN A BIOLOGICAL SAMPLE AND METHODS FOR DETECTING NASH IN A SUBJECT